“…21 Although PE-NHL arising in skeletal bone, 4 and reports on small series of oral PE-NHL suggested a better prognosis for bone localisation, reported larger series of oral PE-NHL do not show this prognostic impact of primary tumour localisation. 5,19 Follow-up of the newly included six PE-NHL patients was too short to include for statistical analysis, but in our previous study, 21 as in other studies 5,19 there was no statistically significant difference in survival time between patients with bone versus soft tissue localisation of the PE-NHL. Besides, determination of tumour localisation, primarily having an intraosseous or soft tissue origin, carries some subjectivity.…”